Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

AURO-LEVETIRACETAM 250 MG

LEVETIRACETAM : 250 MG · DIN 02375249 · AURO PHARMA INC

Health Canada status: MARKETED

What is AURO-LEVETIRACETAM?

AURO-LEVETIRACETAM 250 MG contains LEVETIRACETAM : 250 MG. It is listed in the Health Canada Drug Product Database under DIN 02375249, held by AURO PHARMA INC, supplied as TABLET for ORAL administration. Health Canada currently lists it as marketed, status dated 14-Feb-2012. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.

What is AURO-LEVETIRACETAM used for?

Auro-Levetiracetam (levetiracetam) is indicated as adjunctive therapy in the management of adult (> 18 years of age) patients with epilepsy who are not satisfactorily controlled by conventional therapy.

Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.

Product details and regulatory record

DIN02375249
Brand nameAURO-LEVETIRACETAM
Generic / active ingredientLEVETIRACETAM : 250 MG
ManufacturerAURO PHARMA INC
Strength250 MG
Dosage formTABLET
Route of administrationORAL
SchedulePrescription
ATC codeN03AX14 LEVETIRACETAM
AHFS class28:12.92
BiosimilarNo
Health Canada statusMARKETED
Status date14-Feb-2012
Original market date2012-02-14 00:00:00

How is it stored and handled?

null

How is it supplied?

HDPE bottles of 30’s, 100’s, 120’s and 500’s for 250 mg and 500 mg tablets. HDPE bottles of 30’s, 100’s, 120’s, 250’s and 500’s for 750 mg tablets.

What can be used instead?

Other Canadian products sharing ATC code N03AX14 LEVETIRACETAM. 47 of 109 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.

ProductStrengthFormManufacturerHealth Canada statusDIN
ACH-LEVETIRACETAM250 MGTABLETACCORD HEALTHCARE INCMARKETEDDIN 02399776
ACH-LEVETIRACETAM500 MGTABLETACCORD HEALTHCARE INCMARKETEDDIN 02399784
ACH-LEVETIRACETAM750 MGTABLETACCORD HEALTHCARE INCMARKETEDDIN 02399792
AG-LEVETIRACETAM250 MGTABLETANGITA PHARMA INC.MARKETEDDIN 02485192
AG-LEVETIRACETAM500 MGTABLETANGITA PHARMA INC.MARKETEDDIN 02485206
AG-LEVETIRACETAM750 MGTABLETANGITA PHARMA INC.MARKETEDDIN 02485214
APO-LEVETIRACETAM250 MGTABLETAPOTEX INCMARKETEDDIN 02285924
APO-LEVETIRACETAM500 MGTABLETAPOTEX INCMARKETEDDIN 02285932
APO-LEVETIRACETAM750 MGTABLETAPOTEX INCMARKETEDDIN 02285940
AURO-LEVETIRACETAM500 MGTABLETAURO PHARMA INCMARKETEDDIN 02375257

Who else supplies LEVETIRACETAM worldwide?

Nexara tracks national medicine registries and published price lists across multiple markets. LEVETIRACETAM appears in 1082 registered pack listings across 14 markets, published on 11 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.

Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.

How can I get it?

Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.

Request a quote for AURO-LEVETIRACETAM

Ordering questions

Who can buy this from Nexara?

Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.

Is there a minimum order?

Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.

What is the lead time?

Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.

Can Nexara supply this for a clinical trial?

Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.

Request a quote for AURO-LEVETIRACETAM

Health Canada Drug Product Database (DPD), DIN 02375249. Last reviewed 2026-09-08. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.